Rwanda sits at elevations between 1,000 and 4,507 meters above sea level, with Kigali at approximately 1,567 meters. Visitors arriving from low-altitude locations may experience mild altitude adjustment symptoms during the first two to three days, including headache, fatigue, and sleep disruption. Mount Karisimbi at 4,507 meters and other Virunga Mountains peaks present genuine high-altitude environments where acute mountain sickness can develop in unacclimatized individuals. The Central Plateau where most population centers exist maintains elevations between 1,400 and 1,900 meters. Travelers planning treks to Volcanoes National Park should spend at least two nights at moderate elevation before ascending above 3,000 meters. Physical exertion feels noticeably harder during the first week at these elevations compared to sea level performance.
Malaria transmission occurs throughout Rwanda but varies substantially by region and elevation. Akagera National Park in the eastern lowlands presents high transmission risk year-round, particularly during rainy seasons from February to May and September to December. Lake Kivu shoreline areas including Gisenyi and Cyangugu maintain moderate transmission. Kigali experiences low transmission due to its elevation, urban mosquito control programs, and reduced vector habitat. Nyungwe National Park at elevations between 1,600 and 2,950 meters has minimal transmission risk. The dominant parasite species is Plasmodium falciparum, which causes the most severe form of malaria. Anopheles gambiae mosquitoes transmit the disease primarily between dusk and dawn. Travelers visiting Akagera or spending nights in rural lowland areas should consult a physician regarding chemoprophylaxis options. Mosquito nets are standard in tourist accommodations near Akagera but less common in Kigali hotels.
The Rwanda Biomedical Center documented 35,983 confirmed malaria cases in 2022, down from 4.8 million cases in 2005, representing a 99.2 percent reduction over seventeen years. Indoor residual spraying covers approximately 1.3 million households annually in high-transmission districts. Long-lasting insecticide-treated nets reached 72 percent household coverage by 2020. These control measures have shifted Rwanda from high to low transmission nationwide, but elimination has not occurred. Eastern Province districts including Kayonza, Gatsibo, and Kirehe report the highest current incidence. Nyagatare District near the Uganda border maintains transmission despite elevation due to irrigation systems creating mosquito breeding sites. Travelers spending time exclusively in Kigali, Musanze for gorilla trekking, or Nyungwe Forest face substantially lower risk than those visiting Akagera or staying in rural eastern areas.
Yellow fever vaccination certificate is required for all travelers aged nine months and older arriving from countries with risk of yellow fever transmission. Rwanda updated this requirement in 2016 following World Health Organization International Health Regulations. Travelers arriving from countries not on the yellow fever endemic list do not require vaccination for entry but may require it for return to their home country or onward travel. The vaccine becomes valid 10 days after administration for first-time recipients. A single dose provides lifetime protection, and revaccination is no longer required under current WHO guidelines. King Faisal Hospital in Kigali and University Teaching Hospital of Kigali stock yellow fever vaccine, but travelers should receive vaccination before departure rather than depending on in-country availability.
Rwanda has no indigenous yellow fever transmission. The last documented outbreak occurred in 1991 in Cyangugu Prefecture, with 48 cases reported. Aedes aegypti mosquitoes, the primary yellow fever vector, exist in Rwanda but at low densities compared to West African countries. The government maintains surveillance for arboviral diseases through sentinel sites at district hospitals. Dengue fever has been documented in sporadic cases since 2018, with small outbreaks in Kigali and Eastern Province. Chikungunya cases appear occasionally but do not constitute sustained transmission. Zika virus has not been detected in Rwanda as of 2024. These arboviruses share the same Aedes mosquito vectors, which bite primarily during daylight hours unlike malaria-transmitting Anopheles species.
Routine vaccinations should be current before travel to Rwanda. Measles circulation continues in Central and East Africa despite vaccination programs. Rwanda conducts routine childhood immunization achieving approximately 95 percent coverage for measles-containing vaccine, but immunity gaps exist in adult populations and susceptible children. A measles outbreak in 2019 resulted in 1,234 cases across multiple districts. Tetanus risk exists through any soil-contaminated wound in agricultural areas. Diphtheria has been eliminated from Rwanda with no cases reported since 2003, but the disease circulates in neighboring Democratic Republic of Congo. Pertussis appears in cyclical outbreaks every three to five years. Polio has been eradicated from Rwanda since 1992, with the last wild poliovirus case detected that year. The country uses inactivated polio vaccine in routine immunization.
Hepatitis A transmission occurs through contaminated food and water throughout Rwanda. Seroprevalence studies indicate that most Rwandan adults have acquired immunity through childhood exposure, but non-immune travelers face risk. Street food in Kigali markets, untreated water in rural areas, and food handling in establishments without running water present transmission routes. Hepatitis B prevalence in Rwandan adults is approximately 2.9 percent based on national surveys. Mother-to-child transmission and unsafe medical procedures were historical transmission routes before universal infant vaccination began in 2002. Hepatitis B vaccine became part of Rwanda's pentavalent vaccine in 2002, achieving over 90 percent coverage in birth cohorts since that year. Travelers planning extended stays, those who may require medical procedures, or individuals likely to have intimate contact with residents should consult a physician regarding hepatitis B vaccination.
Typhoid fever occurs in Rwanda through fecal-oral transmission. The Ministry of Health reported 1,847 confirmed typhoid cases in 2018. Transmission concentrates in areas with inadequate sanitation and during rainy seasons when water sources become contaminated. Kigali's municipal water system is chlorinated and generally safe for consumption, but infrastructure gaps exist in peripheral neighborhoods. Rural areas frequently lack treated water access. The conjugate typhoid vaccine provides approximately 85 percent protection for three to five years. This vaccine became available in 2018, replacing older polysaccharide vaccines with lower efficacy. Travelers planning rural stays exceeding two weeks or those unable to maintain strict food and water precautions should consider vaccination.
Cholera has caused periodic outbreaks in Rwanda, typically imported from neighboring countries rather than sustained endemic transmission. A major outbreak from March to July 2022 involved 684 cases and 13 deaths, concentrated in Rubavu District near the Democratic Republic of Congo border. The epidemic strain matched concurrent outbreaks in South Kivu Province across Lake Kivu. Previous outbreaks occurred in 2016 (217 cases) and 2012 (42 cases). Rwanda responded to the 2022 outbreak with oral cholera vaccination campaigns covering 433,000 people in Rubavu, Rusizi, and surrounding districts. Cholera transmission links to contaminated water in Lake Kivu, where fishing communities have limited sanitation infrastructure. Travelers staying in standard accommodations face minimal risk, but those visiting fishing villages or refugee settlements near western borders face elevated exposure.
Rabies exists in Rwanda with approximately 100 to 150 human cases reported annually, though actual incidence likely exceeds reported figures. Dogs cause 99 percent of human rabies transmissions. A 2012 survey estimated 300,000 dogs in Rwanda, with 15 to 20 percent vaccination coverage at that time. The government launched mass dog vaccination campaigns in 2013 reaching approximately 50 to 60 percent coverage in targeted districts. Stray dog populations exist in all cities and rural areas. Post-exposure prophylaxis requires rabies immunoglobulin and vaccine series administered within days of exposure. King Faisal Hospital in Kigali stocks both products, but availability in rural district hospitals is inconsistent. Pre-exposure vaccination requires three doses over three to four weeks and simplifies post-exposure treatment by eliminating the need for immunoglobulin. Travelers planning extended rural stays, working with animals, or engaging in activities like cycling where dog encounters are likely should consult a physician regarding pre-exposure vaccination.